Stable poly(imidazolium) hydroxides

US11299464B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11299464-B2
Application numberUS-201716321414-A
CountryUS
Kind codeB2
Filing dateJul 29, 2017
Priority dateJul 29, 2016
Publication dateApr 12, 2022
Grant dateApr 12, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are imidazolium polymers having steric hindrance at the 4-position of the imidazole moieties in the polymeric chain. The sterically-protected, N-methylated imidazolium polymers exhibit hydroxide stability in concentrated caustic solutions at elevated temperatures, such as at 100° C. and higher.

First claim

Opening claim text (preview).

The embodiments of the disclosure in which an exclusive property or privilege is claimed are defined as follows: 1. A polymer comprising a repeating unit of Formula (I): wherein: R 1 , R 2 , R 4 , and R 5 are each independently selected from absent, alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl; provided that at least one of R 1 and R 2 is selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl, when one of R 1 and R 2 is absent, the imidazolyl group to which the absent R 1 or R 2 is connected is neutral; and at least one of R 4 and R 5 is selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl; and when one of R 4 and R 5 is absent, the imidazolyl group to which the absent R 4 or R 5 is connected is neutral; R 3 and R 6 are each independently selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, aralkyl, and heteroaryl; R 15 is arylene optionally substituted with 1, 2, 3, or 4 substituents independently selected from alkyl, perfluoroalkyl, heteroalkyl, and halo; R 16 is arylene optionally substituted with 1, 2, 3, or 4 substituents independently selected from alkyl, perfluoroalkyl, heteroalkyl, and halo; R 7 , R 10 , R 11 , and R 14 are each independently selected from alkyl, perfluoroalkyl, and heteroalkyl; and R 8 , R 9 , R 12 , and R 13 are each independently selected from hydrogen, alkyl, perfluoroalkyl, and heteroalkyl. 2. The polymer of claim 1 , wherein the polymer comprises a repeating unit of Formula (I-A): wherein: R 1 , R 2 , R 4 , and R 5 are each independently selected from absent, alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl; provided that at least one of R 1 and R 2 is selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl, when one of R 1 and R 2 is absent, the imidazolyl group to which the absent R 1 or R 2 is connected is neutral; at least one of R 4 and R 5 is selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl; and when one of R 4 and R 5 is absent, the imidazolyl group to which the absent R 4 or R 5 is connected is neutral; R 3 and R 6 are each independently selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, aralkyl, and heteroaryl; R 15 is arylene optionally substituted with 1, 2, 3, or 4 substituents independently selected from alkyl, perfluoroalkyl, heteroalkyl, and halo; R 16 is arylene optionally substituted with 1, 2, 3, or 4 substituents independently selected from alkyl, perfluoroalkyl, heteroalkyl, and halo; R 7 , R 10 , R 11 , and R 14 are each independently selected from alkyl, perfluoroalkyl, and heteroalkyl; and R 8 , R 9 , R 12 , and R 13 are each independently selected from hydrogen, alkyl, perfluoroalkyl, and heteroalkyl. 3. The polymer of claim 1 , wherein the polymer comprises a repeating unit of Formula (I-B): wherein: R 1 , R 2 , R 4 , and R 5 are each independently selected from absent, alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl; provided that at least one of R 1 and R 2 is selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl, when one of R 1 and R 2 is absent, the imidazolyl group to which the absent R 1 or R 2 is connected is neutral; and at least one of R 4 and R 5 is selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl; and when one of R 4 and R 5 is absent, the imidazolyl group to which the absent R 4 or R 5 is connected is neutral; R 3 and R 6 are each independently selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, aralkyl, and heteroaryl; R 15 is arylene optionally substituted with 1, 2, 3, or 4 substituents independently selected from alkyl, perfluoroalkyl, heteroalkyl, and halo; R 16 is arylene optionally substituted with 1, 2, 3, or 4 substituents independently selected from alkyl, perfluoroalkyl, heteroalkyl, and halo; R 7 , R 10 , R 11 , and R 14 are each independently selected from alkyl, perfluoroalkyl, and heteroalkyl; and R 8 , R 9 , R 12 , and R 13 are each independently selected from hydrogen, alkyl, perfluoroalkyl, and heteroalkyl. 4. The polymer of claim 1 , wherein the polymer comprises a repeating unit of Formula (I-C): wherein: R 1 , R 2 , R 4 , and R 5 are each independently selected from absent, alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl; provided that at least one of R 1 and R 2 is selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl, when one of R 1 and R 2 is absent, the imidazolyl group to which the absent R 1 and R 2 is connected is neutral; and at least one of R 4 and R 5 is selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl; and when one of R 4 and R 5 is absent, the imidazolyl group to which the absent R 4 or R 5 is connected is neutral; R 3 and R 6 are each independently selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, aralkyl, and heteroaryl; R 15 is arylene optionally substituted with 1, 2, 3, or 4 substituents independently selected from alkyl, perfluoroalkyl, heteroalkyl, and halo; R 16 is arylene optionally substituted with 1, 2, 3, or 4 substituents independently selected from alkyl, perfluoroalkyl, heteroalkyl, and halo; R 7 , R 10 , R 11 , and R 14 are each independently selected from alkyl, perfluoroalkyl, and heteroalkyl; and R 8 , R 9 , R 12 , and R 13 are each independently selected from hydrogen, alkyl, perfluoroalkyl, and heteroalkyl. 5. The polymer of claim 1 , wherein the polymer comprises a repeating unit of Formula (I-D): wherein: R 1 , R 2 , R 4 , and R 5 are each independently selected from absent, alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl; provided that at least one of R 1 and R 2 is selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl, when one of R 1 and R 2 is absent, the imidazolyl group to which the absent R 1 or R 2 is connected is neutral; and at least one of R 4 and R 5 is selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl; and when one of R 4 and R 5 is absent, the imidazolyl group to which the absent R 4 or R 5 is connected is neutral; R 3 and R 6 are each independently selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, aralkyl, and heteroaryl; R 15 is arylene optionally substituted with 1, 2, 3, or 4 substituents independently selected from alkyl, perfluoroalkyl, heteroalkyl, and halo; R 16 is arylene optionally substituted with 1, 2, 3, or 4 substituents independently selected from alkyl, perfluoroalkyl, heteroalkyl, and halo; R 7 , R 10 , R 11 , and R 14 are each independently selected from alkyl, perfluoroalkyl, and heteroalkyl; and R 8 , R 9 , R 12 , and R 13 are each independently selected from hydrogen, alkyl, perfluoroalkyl, and heteroalkyl. 6. The polymer of claim 1 , wherein R 1 , R 2 , R 4 , and R 5 are each independently selected from absent, methyl, and trifluoromethyl; provided that at least one of R 1 and R 2 is selected from methyl and trifluoromethyl; and at least one of R 4 and R 5

Assignees

Inventors

Classifications

  • A61P31/00Primary

    Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title

  • C07D233/64Primary

    with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine · CPC title

  • with only two nitrogen atoms in the ring · CPC title

  • Amines · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11299464B2 cover?
Provided herein are imidazolium polymers having steric hindrance at the 4-position of the imidazole moieties in the polymeric chain. The sterically-protected, N-methylated imidazolium polymers exhibit hydroxide stability in concentrated caustic solutions at elevated temperatures, such as at 100° C. and higher.
Who is the assignee on this patent?
Univ Fraser Simon
What technology area does this patent fall under?
Primary CPC classification A61P31/00. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).